Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05101239 · ClinicalTrials.gov registry record

Acute and Mild TBI Injury in Military and Civilian Population Using Advanced MR Imaging

A clinical trial of Mild Traumatic Brain Injury, sponsored by The Geneva Foundation.

Active
Registry status
160
Enrollment target
2
Study locations

NCT05101239 is a study of Mild Traumatic Brain Injury that is active but no longer recruiting, run by The Geneva Foundation. The registered enrollment target is 160 participants, below the 217-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (26% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05101239, a study of Mild Traumatic Brain Injury, is active but no longer recruiting, sponsored by The Geneva Foundation.

ACTIVE NOT RECRUITING
Registry status
160 participants
Enrollment target
2
Study locations

Study Summary

This is a prospective longitudinal study of patients with acute mTBI and comparison with chronic mTBI patients and a cohort without history of TBI or none within 5 years of enrollment. The patients will be recruited from the eligible population at military medical centers in the National Capital Region.

Interventions

  • DEVICE MRI imaging exam

Study Locations (2)

Maryland

  • Walter Reed National Military Medical Center - Bethesda

Virginia

  • Fort Belvoir Community Hospital - Fort Belvoir

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2019-11-08
Est. Completion 2026-06-30

Sponsor

The Geneva Foundation

11 total trials

What the Registry Record Tells You About NCT05101239

The ClinicalTrials.gov registry entry for NCT05101239 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 217-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (26% lower). The listed sponsor is The Geneva Foundation, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which MRI imaging exam is the first listed.

NCT05101239 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Virginia.

Frequently Asked Questions

What is clinical trial NCT05101239 about?

NCT05101239 is a clinical study titled "Acute and Mild TBI Injury in Military and Civilian Population Using Advanced MR Imaging". This is a prospective longitudinal study of patients with acute mTBI and comparison with chronic mTBI patients and a cohort without history of TBI or none within 5 years of enrollment. The patients will be recruited from the eligible population at military medical centers in the National Capital Reg...

What is the current status of trial NCT05101239?

This trial is currently active not recruiting. The enrollment target is 160 participants. The study started on 2019-11-08. Estimated completion is 2026-06-30.

What conditions does trial NCT05101239 study?

This clinical trial studies the following conditions: Mild Traumatic Brain Injury.

What interventions are being tested in trial NCT05101239?

The interventions under investigation include: MRI imaging exam (DEVICE).

Who is sponsoring clinical trial NCT05101239?

This trial is sponsored by The Geneva Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05101239 being conducted?

This trial has 2 study locations across Maryland, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.